Marker Therapeutics, Inc. Common Stock (NASDAQ: MRKR) last traded at $1.39, up 13.93% on the session. The quote above updates while this page is open; the figures below are drawn from Marker Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Marker Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MRKR. Its market capitalisation is $23.18 million.
Valuation measures for Marker Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $23.18M |
|---|---|
| Enterprise value | $14.26M |
| Price / sales | 5.87 |
| Price / book | 1.91 |
| Beta | 1.05 |
Trailing-twelve-month figures tagged in Marker Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.95M |
|---|---|
| Net income (TTM) | -$8.71M |
| Operating margin | -240.64% |
| Return on equity | -71.57% |
| Cash | $11.33M |
Range and volume for MRKR over the past 52 weeks.
| 52-week high | $2.46 |
|---|---|
| 52-week low | $0.810 |
| Volume | 99.0K |
| Average volume | 62.3K |
| Previous close | $1.22 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.